← Back to Search

Personalized Exercise Programs for Aging-related Functional Decline During Hospitalization

N/A

Recruiting

Led By Fonseca Raquel, Ph. D

Research Sponsored by Université du Québec a Montréal

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

be aged 65 and over

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 2 years

Awards & highlights

Study Summary

This trial will help to determine if physical activity programs should be implemented in geriatric units to help the elderly maintain their functional capacities and mobility.

Who is the study for?

This trial is for older adults aged 65 and over who are hospitalized, planning to be discharged home, can communicate in French or English, have self-awareness, and no contraindications to physical activity. There are no specific exclusion criteria.Check my eligibility

What is being tested?

The study tests three personalized exercise programs: MATCH during hospitalization; PATH at discharge; and PATH 2.0 both during hospitalization and after discharge. The goal is to prevent functional decline in elderly patients by integrating these exercises into routine care.See study design

What are the potential side effects?

Since the interventions involve personalized exercise programs designed for the elderly, side effects may include typical risks associated with physical activity such as muscle soreness or fatigue but will be tailored to minimize any potential harm.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 65 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Changes in muscle strength after intervention (upper muscle strength : handgrip strength, lower limb strength: sit to stand-30sec)

Changes in short physical performance battery (SPPB) after intervention

Changes in walking after intervention (Walking speed :4 m habitual gait speed and walking parameter : 3 meter timed up and go)

Secondary outcome measures

Acceptability of the clinical tools: MATCH, PATH, PATH 2.0

Changes in caregiver burden after intervention

Changes in the length of stay after intervention

+7 more

Trial Design

4Treatment groups

Experimental Treatment

Active Control

Group I: Group 3Experimental Treatment1 Intervention

MATCH tool: Prescription of physical exercise programs during hospitalization

Group II: Group 2Experimental Treatment1 Intervention

PATH 2.0 Tool : Prescription of exercise programs during hospitalization and discharge

Group III: Group 1Experimental Treatment1 Intervention

PATH Tool : Prescription of exercise programs at discharge

Group IV: Group 4Active Control1 Intervention

Control group: Usual care by the clinical teams

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Université du Québec a MontréalLead Sponsor

22 Previous Clinical Trials

4,567 Total Patients Enrolled

1 Trials studying Aging

100 Patients Enrolled for Aging

Fonseca Raquel, Ph. DPrincipal InvestigatorUniversité du Québec a Montréal

Marie-Jeanne Kergoat, M.D., FRCPCPrincipal InvestigatorCentre de recherche de l'institut Universitaire de Gériatrie de Montreal

Media Library

MATCH Clinical Trial Eligibility Overview. Trial Name: NCT04078334 — N/A

Aging Clinical Trial 2023: MATCH Highlights & Side Effects. Trial Name: NCT04078334 — N/A

MATCH 2023 Treatment Timeline for Medical Study. Trial Name: NCT04078334 — N/A

Aging Research Study Groups: Group 4, Group 2, Group 1, Group 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any participants being accepted for this clinical trial?

"Based on the most recent update, this clinical investigation is presently searching for volunteers. It was initially listed online back in October of 2020 with its latest edition posted on August 6th 2021."

Answered by AI

Is there a set limit to the amount of participants being accepted for this clinical trial?

"Affirmative. According to the information provided on clinicaltrials.gov, this study is still recruiting participants - it was first made available on October 2nd 2020 and last updated on August 6th 2021. It intends to enrol 720 people from one medical centre."

Answered by AI

What is the primary goal of this medical research endeavor?

"This medical experiment will evaluate the Changes in short physical performance battery (SPPB) of participants over 36 weeks as its primary outcome. Secondary objectives include assessing the Feasibility, Acceptability and Effects of MATCH, PATH and PATH 2.0 between university and non-university hospitals or urban/non-urban areas; evaluating Feasibility of clinical tools like MATCH, PATH and PATH 2.0 through a score expressed in % based on number of patients who have received an PA program relative to those eligible for treatment study; as well as estimating Alterations in length of stay post intervention by calculating hospitalization days."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Personalized Exercises Program Prescription to Prevent Functional Decline Throughout Older Adults Hospitalization

Mylène Aubertin-Leheudre 2020. "Personalized Exercises Program Prescription to Prevent Functional Decline Throughout Older Adults Hospitalization". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04078334.